Saturday 17 October 2026 Export MDGL’s income statement to Excel — free account

Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $958.4 million, up 432.1% from fiscal 2024. In the quarter to June 2026, revenue grew 71.2%, EPS fell 32.9%, free cash flow grew 140.5% and total debt rose 187.9%, each against the same quarter a year earlier.

449.74 10.07 −2.19%

Follow MDGL

Alert me

Market cap: $10.6B
P/E: 0.0×
Fwd P/E: −71.3×
Dividend yield: —
F-score: n/a
Altman Z: 10.48
Beneish M: 0.50
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	0.00	0.00	0.00	0.00
P/S ratio Full definition →		13.92	13.63	13.42	12.19
P/FCF ratio Full definition →		0.00	0.00	0.00	0.00
P/Operating CF Full definition →		129.14	(97.89)	(90.77)	670.81
P/B ratio Full definition →		16.48	21.68	27.96	29.88
Price to Tangible BV Full definition →		16.68	21.95	28.34	30.30
EV/Sales Full definition →		12.88	12.95	13.00	11.80
EV/EBITDA Full definition →		0.00	0.00	0.00	0.00
EV/Operating CF Full definition →		(59.39)	(65.50)	(54.90)	(76.63)
EV/FCF Full definition →		(57.61)	(64.00)	(53.41)	(72.40)
Quick Ratio Full definition →		3.14	3.62	2.97	2.76
Current Ratio Full definition →		3.44	4.01	3.50	3.20
Net Debt/EBITDA Full definition →		6.94	11.34	5.22	9.09
Debt/Assets Full definition →		24.94%	26.98%	27.73%	27.38%
Debt/Equity Full definition →		0.54	0.56	0.63	0.65
Asset Turnover Full definition →		0.61	0.83	1.02	1.14
Operating CF/Net income Full definition →		(0.70)	2.28	1.77	(0.40)
Capex/Depreciation Full definition →		(1.72)	0.16	(3.10)	(2.85)
Interest Coverage Full definition →		(15.30)	(7.18)	(11.86)	(7.09)
Research and Development Expense of Revenue Full definition →		60.57%	36.21%	34.91%	25.03%
Selling, General and Administrative Expense of Revenue Full definition →		72.80%	74.74%	86.25%	79.44%
Intangible Assets out of Total Assets Full definition →		0.01	0.01	0.01	0.01
Share Based Compensation of Revenue Full definition →		9.14%	8.03%	10.93%	9.71%
Graham Net Nets Full definition →		0.06	0.05	0.03	0.03
Graham Number Full definition →		0.00	0.00	0.00	0.00
Earnings Yield Full definition →		(2.59%)	(2.02%)	(2.37%)	(2.40%)
Free Cash Flow Yield Full definition →		(1.61%)	(1.48%)	(1.81%)	(1.34%)
Revenue per Share Full definition →		12.78	14.31	10.72	12.50
Operating CF per Share Full definition →		3.55	(5.95)	(5.77)	0.80
Capex per Share Full definition →		(0.17)	0.02	(0.13)	(0.15)
Free Cash Flow per Share Full definition →		3.38	(5.93)	(5.90)	0.65
Cash per Share Full definition →		49.58	44.07	28.17	28.78
Shareholders Equity per Share Full definition →		27.83	26.87	18.72	17.97
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		27.83	26.87	18.72	17.97
Free Cash Flow Full definition →		75.99	(133.07)	(171.28)	19.08
Working Capital Full definition →		955.27	935.48	844.05	824.98
Capital Expenditures Full definition →		(3.86)	0.39	(3.85)	(4.25)
Net Current Asset Value Full definition →		609.96	588.87	498.43	478.26
EV/EBIT Full definition →		0.00	0.00	0.00	0.00
Capex to Sales Full definition →		0.01	0.00	0.01	0.01
Price to Operating Income Full definition →		0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →		71.87	94.15	124.39	135.77
Average Payables Full definition →		45.45	46.24	51.43	36.24
Average Inventory Full definition →		39.02	54.45	83.66	81.44
Average Assets Full definition →		1,217.86	1,150.92	1,111.98	1,130.01
Average Common Equity Full definition →		701.44	678.54	627.05	609.85

Fold the line items

Columns are period end dates

Stockrow Weekly